Effect of Crocin in treatment of breast cancer
Phase 2
Recruiting
- Conditions
- Malignant neoplasm of breast.Malignant neoplasm of breast
- Registration Number
- IRCT20160706028815N4
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Newly diagnosed invasive breast cancer
The Karnofsky Performance Scale Index equal to or more than 70%
doxorubicin containing chemotherapy regimen
Unilateral breast cancer
Age between 18 to 70 years old
Exclusion Criteria
chronic liver failure
chronic kidney failure
chronic heart failure
previous history of hematologic malignancies
History of taking Psychiatric drugs
Warfarin usage
Bipolar mood disorder
Evidence of metastasis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Survival. Timepoint: Every 3 months in the first year, every 4-6 months in the second year, every 6 months in third to fifth years and then annually. Method of measurement: visit.;Progression-free Survival. Timepoint: Every 3 months in the first year, every 4-6 months in the second year, every 6 months in third to fifth years and then annually. Method of measurement: Visit.
- Secondary Outcome Measures
Name Time Method